Agili C News Today

Smith+Nephew plc struck a deal to acquire Cartiheal Ltd. for $180 million at closing and $150 million in contingent payments, seven months after Bioventus Inc. backed out of its agreement to buy the developer of the Agili-C cartilage regeneration platform for $450 million.

Here are 11 key updates on orthobiologics from the third quarter of 2023:

Orthopedic surgeon Ken Zaslav, MD, performed the first commercial case with CartiHeals Agili-C in the U.S., the medtech company said July 26.